136 related articles for article (PubMed ID: 15510613)
1. Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype.
Grieu F; Powell B; Beilby J; Iacopetta B
Anticancer Res; 2004; 24(5B):3215-9. PubMed ID: 15510613
[TBL] [Abstract][Full Text] [Related]
2. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
[TBL] [Abstract][Full Text] [Related]
4. Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy.
Paré L; Altés A; Ramón y Cajal T; Del Rio E; Alonso C; Sedano L; Barnadas A; Baiget M
Anticancer Drugs; 2007 Aug; 18(7):821-5. PubMed ID: 17581305
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase promoter tandem repeat and MTHFD1 R653Q polymorphisms modulate the risk for migraine conferred by the MTHFR T677 allele.
Oterino A; Valle N; Pascual J; Bravo Y; Muñoz P; Castillo J; Ruiz-Alegría C; Sánchez-Velasco P; Leyva-Cobián F; Cid C
Brain Res Mol Brain Res; 2005 Sep; 139(1):163-8. PubMed ID: 15953655
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population.
Ko KH; Kim NK; Yim DJ; Hong SP; Park PW; Rim KS; Kim S; Hwang SG
Anticancer Res; 2006; 26(6B):4229-33. PubMed ID: 17201138
[TBL] [Abstract][Full Text] [Related]
7. One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan.
Matsuo K; Ito H; Wakai K; Hirose K; Saito T; Suzuki T; Kato T; Hirai T; Kanemitsu Y; Hamajima H; Tajima K
Carcinogenesis; 2005 Dec; 26(12):2164-71. PubMed ID: 16051637
[TBL] [Abstract][Full Text] [Related]
8. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study.
Le Marchand L; Haiman CA; Wilkens LR; Kolonel LN; Henderson BE
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2071-7. PubMed ID: 15598763
[TBL] [Abstract][Full Text] [Related]
9. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer.
Li SY; Rong M; Iacopetta B
Oncol Rep; 2006 Jan; 15(1):221-5. PubMed ID: 16328059
[TBL] [Abstract][Full Text] [Related]
10. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
Huang ZH; Hua D; Li LH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
[TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiński J; Scott RJ; Hamann U
Breast Cancer Res Treat; 2007 Sep; 104(3):299-308. PubMed ID: 17063264
[TBL] [Abstract][Full Text] [Related]
12. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.
Suzuki T; Matsuo K; Hiraki A; Saito T; Sato S; Yatabe Y; Mitsudomi T; Hida T; Ueda R; Tajima K
Carcinogenesis; 2007 Aug; 28(8):1718-25. PubMed ID: 17468511
[TBL] [Abstract][Full Text] [Related]
13. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms.
Shi Q; Zhang Z; Li G; Pillow PC; Hernandez LM; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1477-84. PubMed ID: 15941959
[TBL] [Abstract][Full Text] [Related]
15. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population.
Kim JK; Kim S; Han JH; Kim HJ; Chong SY; Hong SP; Hwang SG; Ahn JY; Cha KY; Oh D; Kim NK
Anticancer Res; 2005; 25(3B):2249-52. PubMed ID: 16158971
[TBL] [Abstract][Full Text] [Related]
17. Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk.
Suzuki T; Matsuo K; Sawaki A; Mizuno N; Hiraki A; Kawase T; Watanabe M; Nakamura T; Yamao K; Tajima K; Tanaka H
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2742-7. PubMed ID: 18843018
[TBL] [Abstract][Full Text] [Related]
18. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Macis D; Maisonneuve P; Johansson H; Bonanni B; Botteri E; Iodice S; Santillo B; Penco S; Gucciardo G; D'Aiuto G; Rosselli Del Turco M; Amadori M; Costa A; Decensi A
Breast Cancer Res Treat; 2007 Dec; 106(2):263-71. PubMed ID: 17260091
[TBL] [Abstract][Full Text] [Related]
20. Folate intake along with genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase in patients with advanced gastric cancer.
Shitara K; Muro K; Ito S; Sawaki A; Tajika M; Kawai H; Yokota T; Takahari D; Shibata T; Ura T; Ito H; Hosono S; Kawase T; Watanabe M; Tajima K; Yatabe Y; Tanaka H; Matsuo K
Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1311-9. PubMed ID: 20447923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]